Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-02

Clinical Trial Update: Comparison of Insulin Glargine and Regular Insulin Versus NPH and Regular Insulin in the Treatment of T1DM [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing insulin glargine with regular insulin versus NPH and regular insulin for glycemic control in children with type 1 diabetes ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin Glargine (insulin glargine)
  • NPH insulin (insulin isophane)
  • Regular insulin (insulin)

Snippet

Sponsor: King Edward Medical University | Conditions: To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children | Phase 4 | Status: COMPLETED